Burney, P., B. Kato, C. Janson, D. Mannino, M. Studnicka, W. Tan, E. Bateman, A. Koçabas, W.M. Vollmer, T. Gislason, G. Marks, P.A. Koul, L. Gnatiuc, S. Buist, and Burden of Obstructive Lung Disease (BOLD) Study. 2014. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty: a BOLD analysis—authors’ reply. Thorax 69 (9): 869–870.
Burns, D.M. 2003. Epidemiology of smoking-induced cardiovascular disease. Progress in Cardiovascular Diseases 46 (1): 11–29.
Rosenberg, S.R., and R. Kalhan. 2016. Chronic bronchitis in chronic obstructive pulmonary disease. Magnifying why smoking cessation still matters most. Annals of the American Thoracic Society 13 (7): 999–1000.
Keto, J., H. Ventola, J. Jokelainen, K. Linden, S. Keinänen-Kiukaanniemi, M. Timonen, T. Ylisaukko-oja, and J. Auvinen. 2016. Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open Heart 3 (2): e000358.
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. 2014. The health consequences of smoking-50 years of progress: a report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention (US).
Bluhm, A.L., J. Weinstein, and J.A. Sousa. 1971. Free radicals in tobacco smoke. Nature 229 (5285): 500.
Ding, Y.S., L. Zhang, R.B. Jain, N. Jain, R.Y. Wang, D.L. Ashley, and C.H. Watson. 2008. Levels of tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons in mainstream smoke from different tobacco varieties. Cancer Epidemiology, Biomarkers & Prevention 17 (12): 3366–3371.
Messner, B., and D. Bernhard. 2014. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 34 (3): 509–515.
Johannsen, A., C. Susin, and A. Gustafsson. 2014. Smoking and inflammation: evidence for a synergistic role in chronic disease. Periodontol 64 (1): 111–126.
Sundar, I.K., H. Yao, and I. Rahman. 2013. Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxidants & Redox Signaling 18 (15): 1956–1971.
Lo Tam Loi, A.T., S.J.M. Hoonhorst, L. Franciosi, R. Bischoff, R.F. Hoffmann, I. Heijink, A.J.M. van Oosterhout, H.M. Boezen, W. Timens, D.S. Postma, J.W. Lammers, L. Koenderman, and N.H.T. ten Hacken. 2013. Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study. BMJ Open 3 (2): e002178.
Lee, J., V. Taneja, and R. Vassallo. 2012. Cigarette smoking and inflammation: cellular and molecular mechanisms. Journal of Dental Research 91 (2): 142–149.
Ashley, D.L., et al. 2008. The scientific basis of tobacco product regulation. World Health Organization Technical Report Series (951): 1–277.
Zeller, M., D. Hatsukami, and Strategic Dialogue on Tobacco Harm Reduction Group. 2009. The strategic dialogue on tobacco harm reduction: a vision and blueprint for action in the US. Tobacco Control 18 (4): 324–332.
Lee, P.N. 2013. Epidemiological evidence relating snus to health--an updated review based on recent publications. Harm Reduction Journal 10: 36.
Hecht, S.S. 2006. Re: Foulds and Ramstrom: cancer causes and control 17: 227-228 (2006) and Henley et al., cancer causes and control 16: 347-358 (2005). How smokeless tobacco can cause lung cancer. Cancer Causes & Control 17 (6): 859–860.
Royal College of Physicians. 2016. Nicotine without smoke: tobacco harm reduction. London: Royal College of Physicians.
Nutt, D.J., L.D. Phillips, D. Balfour, H.V. Curran, M. Dockrell, J. Foulds, K. Fagerstrom, K. Letlape, A. Milton, R. Polosa, J. Ramsey, and D. Sweanor. 2014. Estimating the harms of nicotine-containing products using the MCDA approach. European Addiction Research 20 (5): 218–225.
Gao, H., G.L. Prasad, and W. Zacharias. 2014. Combusted but not smokeless tobacco products cause DNA damage in oral cavity cells. Environmental Toxicology and Pharmacology 37 (3): 1079–1089.
Malpass, G.E., S. Arimilli, G.L. Prasad, and A.C. Howlett. 2014. Regulation of gene expression by tobacco product preparations in cultured human dermal fibroblasts. Toxicology and Applied Pharmacology 279 (2): 211–219.
Arimilli, S., B.E. Damratoski, and G.L. Prasad. 2013. Combustible and non-combustible tobacco product preparations differentially regulate human peripheral blood mononuclear cell functions. Toxicology In Vitro 27 (6): 1992–2004.
Holt, P.G., and D. Keast. 1977. Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriological Reviews 41 (1): 205–216.
Qiu, S.L., H. Zhang, Q.Y. Tang, J. Bai, Z.Y. He, J.Q. Zhang, M.H. Li, J.M. Deng, G.N. Liu, and X.N. Zhong. 2017. Neutrophil extracellular traps induced by cigarette smoke activate plasmacytoid dendritic cells. Thorax 72 (12): 1084–1093.
Kislina, A., L. Balode, N. Jurka, Z. Sinkevica, S. Isajevs, D. Isajeva, V. Gordjusina, M. Bukovskis, I. Taivans, and G. Strazda. 2015. Increased innate and adaptive immune responses in induced sputum of young smokers. Medicina (Kaunas, Lithuania) 51 (3): 159–166.
Green, R.M., F. Gally, J.G. Keeney, S. Alper, B. Gao, M. Han, R.J. Martin, A.R. Weinberger, S.R. Case, M.N. Minor, and H.W. Chu. 2009. Impact of cigarette smoke exposure on innate immunity: a Caenorhabditis elegans model. PLoS One 4 (8): e6860.
Willis, D., et al. 2012. Toxicology of smokeless tobacco: implications for immune, reproductive, and cardiovascular systems. Journal of Toxicology and Environmental Health Part B, Critical Reviews 15 (5): 317–331.
Arimilli, S., B.E. Damratoski, and L.P. G. 2015. Methods to evaluate cytotoxicity and immunosuppression of combustible tobacco product preparations. Journal of Visualized Experiments (95): 52351.
Putney, J.W., Jr., Broad, L.M., Braun, F.J., Lievremont, J.P., Bird, G.S. 2001. Mechanisms of capacitative calcium entry. Journal of Cell Science 114 (12): 2223–2229.
Sachs, F. 2010. Stretch-activated ion channels: what are they? Physiology (Bethesda) 25 (1): 50–56.
Cho, M.R., et al. 1999. Transmembrane calcium influx induced by ac electric fields. The FASEB Journal 13 (6): 677–683.
Clapham, D.E. 2003. TRP channels as cellular sensors. Nature 426 (6966): 517–524.
Putney, J.W., Jr. 1997. Type 3 inositol 1,4,5-trisphosphate receptor and capacitative calcium entry. Cell Calcium 21 (3): 257–261.
Putney, J.W., Jr. 1986. A model for receptor-regulated calcium entry. Cell Calcium 7 (1): 1–12.
Philipp, S., B. Strauss, D. Hirnet, U. Wissenbach, L. Méry, V. Flockerzi, and M. Hoth. 2003. TRPC3 mediates T-cell receptor-dependent calcium entry in human T-lymphocytes. The Journal of Biological Chemistry 278 (29): 26629–26638.
Putney, J.W., Jr. 2005. Capacitative calcium entry: sensing the calcium stores. The Journal of Cell Biology 169 (3): 381–382.
Venkatachalam, K., H.T. Ma, D.L. Ford, and D.L. Gill. 2001. Expression of functional receptor-coupled TRPC3 channels in DT40 triple receptor InsP3 knockout cells. The Journal of Biological Chemistry 276 (36): 33980–33985.
Bertin, S., et al. 2014. The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4(+) T cells. Nature Immunology 15 (11): 1055–1063.
Gouy, H., D. Cefai, S.B. Christensen, P. Debré, and G. Bismuth. 1990. Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin. European Journal of Immunology 20 (10): 2269–2275.
Telford, W.G., and R.A. Miller. 1996. Detection of plasma membrane Ca(2+)-ATPase activity in mouse T lymphocytes by flow cytometry using fluo-3-loaded vesicles. Cytometry 24 (3): 243–250.
Bautista, D.M., M. Hoth, and R.S. Lewis. 2002. Enhancement of calcium signalling dynamics and stability by delayed modulation of the plasma-membrane calcium-ATPase in human T cells. The Journal of Physiology 541(Pt 3: 877–894.
Hallett, M.B., and D. Lloyds. 1997. The molecular and ionic signaling of neutrophils. Molecular Biology Intelligence Unit, 180. Berlin/Heidelberg: Springer-Verlag Berlin and Heidelberg GmbH & Co.
Parekh, A.B., and J.W. Putney Jr. 2005. Store-operated calcium channels. Physiological Reviews 85 (2): 757–810.
Arimilli, S., E. Schmidt, B.E. Damratoski, and G.L. Prasad. 2017. Role of oxidative stress in the suppression of immune responses in peripheral blood mononuclear cells exposed to combustible tobacco product preparation. Inflammation 40 (5): 1622–1630.
Misra, M., R. Leverette, B. Cooper, M. Bennett, and S. Brown. 2014. Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. International Journal of Environmental Research and Public Health 11 (11): 11325–11347.
Arimilli, S., B.E. Damratoski, B. Bombick, M.F. Borgerding, and G.L. Prasad. 2012. Evaluation of cytotoxicity of different tobacco product preparations. Regulatory Toxicology and Pharmacology 64 (3): 350–360.
Wylam, M.E., V. Sathish, S.K. VanOosten, M. Freeman, D. Burkholder, M.A. Thompson, C.M. Pabelick, and Y.S. Prakash. 2015. Mechanisms of cigarette smoke effects on human airway smooth muscle. PLoS One 10 (6): e0128778.
Rasmussen, J.E., J.T. Sheridan, W. Polk, C.M. Davies, and R. Tarran. 2014. Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. The Journal of Biological Chemistry 289 (11): 7671–7681.
Sassano, M.F., A. Ghosh, and R. Tarran. 2017. Tobacco smoke constituents trigger cytoplasmic calcium release. Applied In Vitro Toxicology 3 (2): 193–198.
Mai, Y., T. Higashi, K. Terada, C. Hatate, P. Nepal, M. Horiguchi, T. Harada, S. Miwa, and T. Horinouchi. 2012. Nicotine- and tar-free cigarette smoke extract induces cell injury via intracellular Ca2+-dependent subtype-specific protein kinase C activation. Journal of Pharmacological Sciences 120 (4): 310–314.
Venkateswaran, K., A. Verma, A.N. Bhatt, A. Shrivastava, K. Manda, H.G. Raj, A. Prasad, C. Len, V.S. Parmar, and B.S. Dwarakanath. 2018. Emerging roles of calreticulin in cancer: implications for therapy. Current Protein & Peptide Science 19 (4): 344–357.
Chemaly, E.R., L. Troncone, and D. Lebeche. 2018. SERCA control of cell death and survival. Cell Calcium 69: 46–61.
Danese, A., S. Patergnani, M. Bonora, M.R. Wieckowski, M. Previati, C. Giorgi, and P. Pinton. 2017. Calcium regulates cell death in cancer: roles of the mitochondria and mitochondria-associated membranes (MAMs). Biochimica et Biophysica Acta - Bioenergetics 1858 (8): 615–627.
Voelkers, M., et al. 2010. Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes. Journal of Molecular and Cellular Cardiology 48 (6): 1329–1334.